Novo Nordisk just announced price cuts for Ozempic and Wegovy, whose list prices as recently as last year were around $1,000 ...

Patients on popular GLP-1 weight-loss and diabetes jabs should be monitored for suicidal behaviour, the TGA says, while ...

The explosive rise of drugs like Ozempic and Mounjaro is shifting consumption patterns, health outcomes and pushing ...

The weight loss market has become one of the hottest areas in the pharmaceutical industry. Investors looking to capitalize on ...

The alarming trend spotted amongst GLP-1 users means some patients cannot lift their limbs due to nerve dysfunction.

Research is important to us for many reasons. Sometimes, for example, research results in a new treatment (e.g., Alexander ...

Share on PinterestNovo Nordisk has announced the cessation of the Evoke trials, looking at whether GLP-1 drugs could help ...

Meghan Trainor decided to quit drinking coffee after a psychic told her husband, Daryl Sabara, that her caffeine intake was ...

The high-profile Australian start-up more than doubled its revenue in the year ending June 30, driven by strong demand in the ...

CHRISTMAS will be very merry for three million fat jab users — as they are likely to get drunk quickly. Doctors have issued a ...

Semaglutide, the drug behind the blockbuster weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline in people with early-stage Alzheimer's, according to two large new studies.

Interest in therapies that support weight management has grown rapidly as new metabolic medicines reshape treatment choices ...